Publisher: GlobalData
Category: Pharmaceuticals

Pharmaceuticals market research reports by GlobalData

(1,814 reports matching your criteria)
    • Traws Pharma Inc (TRAW) - Financial and Strategic SWOT Analysis Review

      Traws Pharma Inc (TRAW) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ... Read More

    • Vimta Labs Ltd (VIMTALABS) - Financial and Strategic SWOT Analysis Review

      Vimta Labs Ltd (VIMTALABS) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes ... Read More

    • Torii Pharmaceutical Co Ltd (4551) - Financial and Strategic SWOT Analysis Review

      Torii Pharmaceutical Co Ltd (4551) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More

    • Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review

      Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a ... Read More

    • Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review

      Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne ... Read More

    • Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

      Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Se ... Read More

    • Harrow Inc (HROW) - Financial and Strategic SWOT Analysis Review

      Harrow Inc (HROW) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t ... Read More

    • Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review

      Taiho Pharmaceutical Co Ltd - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ ... Read More

    • Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review

      Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w ... Read More

    • Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

      Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Glaucoma Surgery Devices Pipeline Report including Stages of Development, Segments, Region and ... Read More

    • Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

      Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segm ... Read More

    • Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

      Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Insulin Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regu ... Read More

    • Burzynski Research Institute Inc (BZYR) - Financial and Strategic SWOT Analysis Review

      Burzynski Research Institute Inc (BZYR) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength ... Read More

    • Galderma SA (GALD) - Financial and Strategic SWOT Analysis Review

      Galderma SA (GALD) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and ... Read More

    • Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review

      Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse ... Read More

    • Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review

      Checkpoint Therapeutics Inc (CKPT) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More

    • Skinvisible Inc (SKVI) - Financial and Strategic SWOT Analysis Review

      Skinvisible Inc (SKVI) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ... Read More

    • Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review

      Phoenix Pharmahandel GmbH & Co KG - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major ... Read More

    • Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review

      Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses ... Read More

    • Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review

      Navamedic ASA (NAVA) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an ... Read More

    • Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review

      Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an ... Read More

    • Esophageal Cancer: Competitive Landscape

      Esophageal Cancer: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. In 2024, more than 410,000 diagnosed incident cases of EC are anticipated in the 16 countries covered in GlobalData’s epide ... Read More

    • Sepsis: Epidemiology Forecast to 2033

      Sepsis: Epidemiology Forecast to 2033 Summary Sepsis is a life-threatening complication arising from an infection, which occurs when the body’s response to the infection damages its own tissues and organs. Sepsis causes multiple organ failure and death, especially if it is not recognized early and t ... Read More

    • Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape

      Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Limb-Girdle Muscular Dystrophy therapeutics. In 2024, more than 111,000 diagnosed prevalent cases of LGMD are anticipated in the 16 cou ... Read More

    • Gonorrhea (GN): Competitive Landscape

      Gonorrhea (GN): Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Gonorrhea therapeutics. In 2024, more than 3.7 million diagnosed incident cases of GN are anticipated in the 16 countries covered in GlobalData’s epidemiology ... Read More

1 2 3 4 5 6 7 8 9 10

Cookie Settings